CymaBay Therapeutics, Inc. (CBAY) has seen some recent activity in the marketplace and its shares closed trading at $7.89 yesterday. People are starting to take interest of CBAY as the shares traded as high as $8.01 and as low as $7.63 in the previous market session.
CymaBay Therapeutics, Inc. (CBAY) average trading volume is 3.66M. However, in the previous market session CymaBay Therapeutics, Inc. (CBAY) exchanged 1,143,502 shares. The First downside support level on CBAY is $7.80. CBAY fifty day moving average is $6.63 and CBAY 200-day moving average is $4.27.
CymaBay Therapeutics, Inc. (CBAY) most current performance has been specified by the recent movement in CBAY shares. CBAY has performed 36.27% over the past 4 weeks, CBAY has performed 136.94% over the past 3 months and CBAY has shown 74.56% over the past 1 year. CymaBay Therapeutics, Inc. (CBAY) has a 12 month range of $1.21 to $8.39. CymaBay Therapeutics, Inc. (CBAY) is trading 552.07% from its 12 month low and -5.96% from its 12 month high. CymaBay Therapeutics, Inc. (CBAY) is displaying a 9.37% short float displaying the sum short in the float.
CBAY has 68.89M shares outstanding and 64.17M shares in the float. CymaBay Therapeutics, Inc. (CBAY) at this time has a market cap of $535.97M and income of -79.50M. The EPS next quarter for CBAY is -0.17 and forecasted EPS next year is -37.50%. The market cap of CymaBay Therapeutics, Inc. (CBAY) at $535.97M represents how many People own shares of CBAY and is based off the last price ($7.89) of CBAY and the sum of shares outstanding (68.89M) with CymaBay Therapeutics, Inc. (CBAY).
CymaBay Therapeutics, Inc. (CBAY) has aggregate cash (mrq) of 168.91M, aggregate cash per share (mrq) of 2.45, aggregate debt of CBAY remains at 1.95M and aggregate debt/equity (mrq) is 1.18. . CymaBay Therapeutics, Inc. (CBAY) running cash flow (ttm) is -73.72M, CBAY leveraged free cash flow (ttm) is -42.22M.
CBAY is trading 14.06% above (bullish) its SMA20, 23.96% above (bullish) its SMA50 and 129.32% above (bullish) its SMA200.
